Citation Impact
Citing Papers
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
The molecular hallmarks of epigenetic control
2016 Standout
Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
2015
Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity
2009
Review article: the role of butyrate on colonic function
2007 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Autophagy and the Integrated Stress Response
2010 Standout
Inference of Macromolecular Assemblies from Crystalline State
2007 Standout
Cellular senescence: when bad things happen to good cells
2007 Standout
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
2004 Standout
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Synthesis of 3,3-diindolyl oxyindoles efficiently catalysed by FeCl3 and their in vitro evaluation for anticancer activity
2010
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Mitochondrial fusion and fission in cell life and death
2010 Standout
Discovery and development of SAHA as an anticancer agent
2007
The Epigenomics of Cancer
2007 Standout
Behavior of Mitochondria in the Living Cell
1990
Anticancer activities of histone deacetylase inhibitors
2006 Standout
A chemical probe toolbox for dissecting the cancer epigenome
2017
Sirt1 modulates premature senescence-like phenotype in human endothelial cells
2007
Schistosomiasis
2018 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Acetylation-Deacetylation of the Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-related Factor 2) Regulates Its Transcriptional Activity and Nucleocytoplasmic Localization
2011
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
2013
New pyrrole-based histone deacetylase inhibitors: Binding mode, enzyme- and cell-based investigations
2008
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
2008
Histone deacetylase inhibitors: molecular mechanisms of action
2007
Autophagy and Aging
2011 Standout
Structural Basis of Inhibition of the Human NAD+-Dependent Deacetylase SIRT5 by Suramin
2007
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Gut microbiota, metabolites and host immunity
2016 Standout
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
2008
The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T
2007
Negative regulation of the deacetylase SIRT1 by DBC1
2008 Nature
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
2008
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells
2009
Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells
2010 StandoutNobel
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Energy Metabolism in the Liver
2014 Standout
A Wound-Isolated Pseudomonas aeruginosa Grows a Biofilm In Vitro Within 10 Hours and Is Visualized by Light Microscopy
2003
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
2013 StandoutNature
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
A General and Selective Iron‐Catalyzed Aminocarbonylation of Alkynes: Synthesis of Acryl‐ and Cinnamides
2010
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Sirtuin inhibitors
2009
OMICS-driven biomarker discovery in nutrition and health
2006
Computational Studies on the Histone Deacetylases and the Design of Selective Histone Deacetylase Inhibitors
2009
Iron Catalysis in Organic Synthesis
2015 Standout
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
2014
Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with an Indole-Containing Cap Group
2013
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Schistosome Sirtuins as Drug Targets
2015
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity
2007
Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
2015
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
Mammalian Sirtuins: Biological Insights and Disease Relevance
2010 Standout
Cytotoxic Effect of Curcumin on Malaria Parasite Plasmodium falciparum : Inhibition of Histone Acetylation and Generation of Reactive Oxygen Species
2006
Histone Deacetylase Inhibitors: From Bench to Clinic
2008
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet‐induced obesity
2007
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Burn Wound Infections
2006 Standout
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
Biomedical Importance of Indoles
2013 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Photobiological activity of exogenous and endogenous porphyrin derivatives in Escherichia coli and Enterococcus hirae cells
2001
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics
2015 Standout
Works of R Pezzi being referenced
Production of bacteriolytic enzymes as a tool for characterizing enterococci
1996
Synthesis and Biological Evaluation of 2-, 3-, and 4-Acylaminocinnamyl-Nhydroxyamides as Novel Synthetic HDAC Inhibitors
2005
Histone deacetylation in epigenetics: An attractive target for anticancer therapy
2005
Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors
2009
Exploring the connection unit in the HDAC inhibitor pharmacophore model: Novel uracil-based hydroxamates
2005
N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors
2009
Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells
2012
Design, Synthesis, and Biological Evaluation of Sirtinol Analogues as Class III Histone/Protein Deacetylase (Sirtuin) Inhibitors
2005
Discovery of (Aryloxopropenyl)pyrrolyl Hydroxyamides as Selective Inhibitors of Class IIa Histone Deacetylase Homologue HD1-A
2003
A rapid staining procedure to demonstrate glycocalyx production and bacterial biofilms.
1994
Class II (IIa)-Selective Histone Deacetylase Inhibitors. 1. Synthesis and Biological Evaluation of Novel (Aryloxopropenyl)pyrrolyl Hydroxyamides
2005
The quantitative estimation of the changes induced by benzydamine in the mitochondria of developing mouse hepatocytes
1969